Lotus Lake Ventures
VC Fund
Beijing, China
Lotus Lake Ventures is an investment firm committed to investing in science and technology innovation enterprises, focusing on high-tech and high-tech enterprises with core competitiveness in the initial stage and growth stage..
- Total investments:
- 78
- Last investment:
- Lead investor:
- 24%
Last updated:
For AI agents: llms.txt
Industries Lotus Lake Ventures invests in
Stages Lotus Lake Ventures invests in
Countries Lotus Lake Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
1 more contact available
Round size
- Seed
- $42k–$72M
- Series A
- $709k–$97M
- Series B
- $2M–$40M
Investment Focus
Industry
- Medical 19 (24%)
- Health Care 19 (24%)
- Biotechnology 17 (22%)
- Manufacturing 12 (15%)
- Pharmaceutical 11 (14%)
Stage
- Series A 23 (29%)
- Series B 20 (26%)
- Seed 12 (15%)
- Angel 6 (8%)
- Series C 5 (6%)
Country
- China 66 (85%)
- India 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Han Zhou
Managing Director
|
Managing Director | Total investments: 1 | Find email | |
|
Jun Xue
Founding Partner
|
Founding Partner | Total investments: 0 | Find email | |
|
Lin Lei
Founding Partner
|
Founding Partner | Total investments: 0 | Find email | |
|
Michael Chen
Associate
|
Associate | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Torrey Pines Medicine is a biotechnology business focused on creating next-generation ultra-long-acting peptide therapies for metabolic illnesses. | Angel / Jul 28, 2026 | |
|
Fulinlan Technology
|
Fulinlan is committed to the planning, design, development, structural analysis, equipment processing and installation of non-standard proprietary equipment, precision parts and other products in the field of aerospace. | Seed / Jun 16, 2026 | |
|
Huanying Medical
|
Huanying Medical specializes in ultrasound technology and independently develops its core components. | Series B / Jun 15, 2026 | |
|
|
Zhongke Qingneng is a green-tech company that specializes in the development and manufacturing of hydrogen liquefaction and cryogenic equipment. | $71.9M / Seed / Feb 01, 2026 | |
|
|
Luanqi Technology is a storage product testing equipment R & D and sales company. | $14.3M / Series B / Jan 16, 2026 | |
|
|
Micro Interventional is a company that develops active interventional innovative medical devices. It emphasizes the development of novel medical devices with a product strategy centered on the precise interventional treatment of coronary heart disease and peripheral arterial disease. | Series A / Dec 16, 2025 | |
|
|
Reprogenix is a groundbreaking medical technology firm that began with stem cell therapy for diabetes and is dedicated to expanding the use of cell therapy in a wide range of disease areas. | $70.3M / Series A / Nov 20, 2025 | |
|
Ronghe Medical
|
Ronghe Medical is a medical device manufacturer specializing in the design, research and development, production, and sales of high-end medical device systems based on advanced energy ablation technology platforms, delivering innovative therapeutic solutions that enhance clinical precision, improve patient outcomes, and support a wide range ofmedical applications. | $14.1M / Series B / Nov 18, 2025 | |
|
|
Null Hypothesis is an AI medical SaaS company that focuses on the development of intelligent medical products using AIGC. | $14.1M / Oct 30, 2025 | |
|
Jinghe Semiconductor
|
Jinghe Semiconductor is a high-tech enterprise specializing in the research, development, and manufacturing of advanced equipment for semiconductor devices, providing cutting-edge solutions that support the production of integrated circuits, microchips, and other core components essential to the global electronics industry. | Seed / Oct 23, 2025 | |
| See all 78 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Lotus Lake Ventures invest in?
Lotus Lake Ventures invests primarily in Medical, Health Care and Biotechnology startups, most often at Series A and Series B stage. Most of the 78 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Lotus Lake Ventures's check size?
Lotus Lake Ventures typically joins rounds of $42k–$72M at Seed, $709k–$97M at Series A and $2M–$40M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Lotus Lake Ventures participates in.
How do I contact Lotus Lake Ventures?
Public channels for Lotus Lake Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Lotus Lake Ventures?
The team at Lotus Lake Ventures includes Han Zhou (Managing Director), Jun Xue (Founding Partner) and Lin Lei (Founding Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!